AEE-788 | Interleukin Related interleukin-related.com

Product Name :
AEE-788

Search keywords :
AEE788

drugId :
null

Target Vo:
Vascular endothelial growth factor receptor 2

Target Vo Short Name :
VEGFR2

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Glioblastoma

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sirtratumab Protocol
Tyrosine Hydroxylase Rabbit mAb Epigenetic Reader Domain
Cytochrome C Antibody: Cytochrome C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 12 kDa, targeting to Cytochrome C. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts